Swiss National Bank Capricor Therapeutics, Inc. Transaction History
Swiss National Bank
- $146 Billion
- Q4 2024
A detailed history of Swiss National Bank transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Swiss National Bank holds 67,400 shares of CAPR stock, worth $1.01 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
67,400Holding current value
$1.01 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CAPR
# of Institutions
112Shares Held
9.76MCall Options Held
1.8MPut Options Held
1.4M-
Vanguard Group Inc Valley Forge, PA2.28MShares$34.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$24.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA879KShares$13.2 Million0.0% of portfolio
-
State Street Corp Boston, MA512KShares$7.7 Million0.0% of portfolio
-
Superstring Capital Management LP New York, NY337KShares$5.07 Million4.49% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $366M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...